Analysis of the interaction of human herpes virus 8 and gp130 in prostate cancer risk.

被引：0
|
作者：
Henning, Jill D. [1 ]
Kercher, Kathrine [2 ]
Bunker, Clareann H. [2 ]
Ferrel, Robert E. [2 ]
Patrick, Alan L. [3 ]
Jenkins, Frank J. [2 ]
机构：
[1] Univ Pittsburgh Johnstown, Johnstown, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Tobago Hlth Studies Off, Scarborough, Tobago, Trinidad Tobago
来源：
CANCER RESEARCH | 2018年 / 78卷 / 16期
关键词：
D O I：
10.1158/1538-7445.PRCA2017-B006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B006
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures
    Passer, B. J.
    Wu, C-l
    Wu, S.
    Rabkin, S. D.
    Martuza, R. L.
    GENE THERAPY, 2009, 16 (12) : 1477 - 1482
  • [32] Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures
    B J Passer
    C-l Wu
    S Wu
    S D Rabkin
    R L Martuza
    Gene Therapy, 2009, 16 : 1477 - 1482
  • [33] Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
    Wyatt, R
    Desjardin, E
    Olshevsky, U
    Nixon, C
    Binley, J
    Olshevsky, V
    Sodroski, J
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9722 - 9731
  • [34] Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients
    Farge, D
    Lebbé, C
    Marjanovic, Z
    Tuppin, P
    Mouquet, C
    Peraldi, HN
    Lang, P
    Hiesse, C
    Antoine, C
    Legendre, C
    Bedrossian, J
    Gagnadoux, HF
    Loirat, C
    Pellet, C
    Sheldon, J
    Golmard, JL
    Agbalika, F
    Schulz, TF
    TRANSPLANTATION, 1999, 67 (09) : 1236 - 1242
  • [35] Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients
    Cattani, P
    Nanni, G
    Graffeo, R
    Capuano, M
    Cerimele, F
    La Parola, IL
    Diociaiuti, A
    Pozzetto, U
    Cerimele, D
    Fadda, G
    Castagneto, M
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (03) : 526 - 527
  • [36] Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
    Siobhan Sutcliffe
    Cathee Till
    Frank J. Jenkins
    Charlotte A. Gaydos
    Phyllis J. Goodman
    Ashraful M. Hoque
    Ann W. Hsing
    Ian M. Thompson
    William G. Nelson
    Angelo M. De Marzo
    Elizabeth A. Platz
    Cancer Causes & Control, 2015, 26 : 35 - 44
  • [37] Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
    Sutcliffe, Siobhan
    Till, Cathee
    Jenkins, Frank J.
    Gaydos, Charlotte A.
    Goodman, Phyllis J.
    Hoque, Ashraful M.
    Hsing, Ann W.
    Thompson, Ian M.
    Nelson, William G.
    De Marzo, Angelo M.
    Platz, Elizabeth A.
    CANCER CAUSES & CONTROL, 2015, 26 (01) : 35 - 44
  • [38] Sequence variance analysis of Human Herpes Virus 8: three distinct strains of virus identified with evidence of geographical segregation.
    O'Leary, JJ
    Kennedy, MM
    Uhlmann, V
    Silva, I
    Howells, D
    Picton, S
    Bardon, A
    Comley, IL
    Jones, RR
    McGee, JO
    JOURNAL OF PATHOLOGY, 1998, 184 : 9A - 9A
  • [39] Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural acid receptor-binding properties distinct from those of human IL-6
    Wan, XY
    Wang, HL
    Nicholas, J
    JOURNAL OF VIROLOGY, 1999, 73 (10) : 8268 - 8278
  • [40] No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: A nested case-control study
    Korodi, Z
    Wang, XH
    Tedeschi, R
    Knekt, P
    Dillner, J
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (12): : 2008 - 2011
12345